La dernière Réunion Générale du consortium MIROCALS a eu lieu les 7 et 8 juin 2018 à Milan pour présenter les avancements du projet.

Humanitas picture


End of trial recruitment phase this autumn

The MIROCALS (Modifying Immune Response and Outcomes in ALS) Clinical Trial is still on-going, with recruitment continuing until the end of September 2019.

Read more

Charities and Patient Associations rally around MIROCALS to show their support

Clinical trials are expensive to run and with several more neurology clinics taking part, ...

Read more

Will Brexit impact on MIROCALS?

As with everything else affected by Brexit, there are probably more questions than answers!

Read more

Ce projet est financé par le programme « Horizon 2020 - Instrument PME » de l’Union européenne sous le numéro de subvention 633413.